Mesoblast (ASX:MSB) posted a 5 per cent increase in revenue in the March quarter, and a 49 per cent increase over the nine months to March 31. The biotech company reported a $US21.3 million ($32.15 million) loss after tax for the quarter, compared to its $US26.5 million loss in the prior year period. Shares are trading flat at $0.98.
Origin Energy (ASX:ORG) updated its earnings guidance amid extreme market volatility across commodity markets, including high coal and gas prices. As a result, the company withdrew all guidance for the 2023 fiscal year and expects 2022 earnings in Energy Markets to be between $310 and $460 million, which is lower than the original guidance of between $450 and $600 million. Shares are trading 11.5 per cent lower at $6.06.
Greenvale Mining (ASX:GRV) is set to acquire an initial 51 per cent stake in geothermal energy company Within Energy. The acquisition aims to provide Greenvale with a clear pathway to fast-track the development of the Alpha Project in Central Queensland. Shares are trading 17.1 per cent higher at $0.21.